フォロー
Jonathan Van Tam
Jonathan Van Tam
Professor of Health Protection, University of Nottingham
確認したメール アドレス: nottingham.ac.uk
タイトル
引用先
引用先
Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study
AB Docherty, EM Harrison, CA Green, HE Hardwick, R Pius, L Norman, ...
bmj 369, 2020
33082020
The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and …
J Mair-Jenkins, M Saavedra-Campos, JK Baillie, P Cleary, FM Khaw, ...
The Journal of infectious diseases 211 (1), 80-90, 2015
11982015
Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score
SR Knight, A Ho, R Pius, I Buchan, G Carson, TM Drake, J Dunning, ...
bmj 370, 2020
9972020
Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual …
SG Muthuri, S Venkatesan, PR Myles, J Leonardi-Bee, TSA Al Khuwaitir, ...
The lancet Respiratory medicine 2 (5), 395-404, 2014
7242014
Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study
OV Swann, KA Holden, L Turtle, L Pollock, CJ Fairfield, TM Drake, S Seth, ...
bmj 370, 2020
6952020
Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre …
APS Munro, L Janani, V Cornelius, PK Aley, G Babbage, D Baxter, M Bula, ...
The Lancet 398 (10318), 2258-2276, 2021
6562021
Infectious virus in exhaled breath of symptomatic seasonal influenza cases from a college community
J Yan, M Grantham, J Pantelic, PJ Bueno de Mesquita, B Albert, F Liu, ...
Proceedings of the National Academy of Sciences 115 (5), 1081-1086, 2018
5782018
Middle East respiratory syndrome
YM Arabi, HH Balkhy, FG Hayden, A Bouchama, T Luke, JK Baillie, ...
New England Journal of Medicine 376 (6), 584-594, 2017
5322017
Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised …
X Liu, RH Shaw, ASV Stuart, M Greenland, PK Aley, NJ Andrews, ...
The Lancet 398 (10303), 856-869, 2021
4812021
Comparative community burden and severity of seasonal and pandemic influenza: results of the Flu Watch cohort study
AC Hayward, EB Fragaszy, A Bermingham, L Wang, A Copas, ...
The Lancet Respiratory Medicine 2 (6), 445-454, 2014
4812014
SARS-CoV-2 (COVID-19): what do we know about children? A systematic review
NS Mehta, OT Mytton, EWS Mullins, TA Fowler, CL Falconer, OB Murphy, ...
Clinical Infectious Diseases 71 (9), 2469-2479, 2020
4522020
Features of 16,749 hospitalised UK patients with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol
AB Docherty, EM Harrison, CA Green, H Hardwick, R Pius, L Norman, ...
MedRxiv, 2020.04. 23.20076042, 2020
4432020
ISARIC4C investigators. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study
AB Docherty, EM Harrison, CA Green, HE Hardwick, R Pius, L Norman, ...
Bmj 369, m1985, 2020
3862020
Reduced neutralisation of SARS-CoV-2 omicron B. 1.1. 529 variant by post-immunisation serum
W Dejnirattisai, RH Shaw, P Supasa, C Liu, ASV Stuart, AJ Pollard, X Liu, ...
The Lancet 399 (10321), 234-236, 2022
3592022
Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults
B Killingley, AJ Mann, M Kalinova, A Boyers, N Goonawardane, J Zhou, ...
Nature Medicine 28 (5), 1031-1041, 2022
3462022
The epidemiology and clinical impact of pandemic influenza
JS Nguyen-Van-Tam, AW Hampson
Vaccine 21 (16), 1762-1768, 2003
3392003
Risk factors for hospitalisation and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave (May–September 2009)
JS Nguyen-Van-Tam, PJM Openshaw, A Hashim, EM Gadd, WS Lim, ...
Thorax 65 (7), 645-651, 2010
3242010
Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data
RH Shaw, A Stuart, M Greenland, X Liu, JSN Van-Tam, MD Snape
The Lancet 397 (10289), 2043-2046, 2021
3202021
Risk prediction of covid-19 related death and hospital admission in adults after covid-19 vaccination: national prospective cohort study
J Hippisley-Cox, CAC Coupland, N Mehta, RH Keogh, K Diaz-Ordaz, ...
bmj 374, 2021
3102021
Reduction in mortality associated with influenza vaccine during 1989-90 epidemic
AH Ahmed, KG Nicholson, JS Nguyen-Van-Tam
The Lancet 346 (8975), 591-595, 1995
3041995
現在システムで処理を実行できません。しばらくしてからもう一度お試しください。
論文 1–20